Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Archives of Dermatological Research
Published in: Archives of Dermatological Research 3/2018

01-04-2018 | Review

Skin barrier and microbiome in acne

Authors: M. A. Rocha, E. Bagatin

Published in: Archives of Dermatological Research | Issue 3/2018

Login to get access

Abstract

Acne is an immune-mediated chronic inflammatory disease. Although several factors are involved in its pathophysiology, this process is not completely understood. Androgen hormone activity increases sebum production inside the pilosebaceous follicle, adjusting the environment for the development of Propionibacterium acnes which triggers inflammation. Knowing how others factors such as the skin barrier and microbiome are involved in acne, can help in understanding more about the disease and may help to conduct a better treatment.
Literature
1.
Baroni A, Buommino E, De Gregorio V et al (2012) Structure and function of epidermis related to barrier properties. Clin Dermatol 30:257–262CrossRefPubMed
2.
3.
Brüggemann H, Henne A, Hoster F et al (2004) The complete genome sequence of Propionibacterium acnes, a commensal of human skin. Science 305:671–673CrossRefPubMed
4.
Brüggemann H (2005) Insights in the pathogenic potential of Propionibacterium acnes from its complete genome. Semin Cutan Med Surg 24:67–72CrossRefPubMed
5.
Burton JL, Cunliffe WJ, Stafford L (1971) The prevalence of acne vulgaris in adolescence. Br J Dermatol 85:119–26CrossRefPubMed
6.
Choi CW, Choi JW, Park KC, Youn SW (2013) Facial sebum affects the development of acne, especially the distribution of inflammatory acne. J Eur Acad Dermatol Venereol 27:301–306CrossRefPubMed
7.
8.
Collier CN, Harper JC, Cafardi JA, Wang W, Foster KW (2008) The prevalence of acne in adults 20 years and older. J Am Acad Dermatol 58:56–9CrossRefPubMed
9.
10.
Del Rosso JQ (2009) Moisturizers: functions, formulation, and clinical applications. In: Draelos ZD (ed) Cosmeceuticals. Saunders Elsevier, Philadelphia, pp 97–102
11.
Del Rosso JQ, Levin J (2011) The clinical relevance of maintaining the functional integrity of the stratum corneum in both healthy and disease-affected skin. J Clin Aesthet Dermatol 4(9):22–42PubMedPubMedCentral
12.
Del Rosso JQ (2011) Topical antibiotics. In: Shalita AR, Del Rosso JQ, Webster GF (eds) Acne vulgaris. Informa Healthcare, London 95–104CrossRef
13.
Del Rosso JQ (2013) Clinical relevance of skin barrier changes associated with the use of oral isotretinoin: the importance of barrier repair therapy in patient management. J Drugs Dermatol 12:626–631PubMed
14.
Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, Knight R (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 107(26):11971–11975CrossRefPubMedPubMedCentral
15.
Downing D, Stewart M, Wertz P, Strauss J (1986) Essential fatty acids and acne. J Am Acad Dermatol 14:221–225CrossRefPubMed
16.
Draelos ZD, Ertel KD, Berge CE (2006) Facilitating facial retinization through barrier improvement. Cutis 78:275–281PubMed
17.
Elias PM (1986) Epidermal effects of retinoids: supramolecular observations and clinical implications. J Am Acad Dermatol 15(4 Pt 2):797–809CrossRefPubMed
18.
Farrah G, Tan E (2016) The use of oral antibiotics in treating acne vulgaris: a new approach. Dermatol Ther 29(5):377–384CrossRefPubMed
19.
20.
Fitz-Gibbon S, Tomida S, Chiu BH et al (2013) Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol 133:2152–2160CrossRefPubMedPubMedCentral
21.
Gollnick H, Cunliffe W, Berson D et al (2003) Management of acne: a report from the global alliance to improve outcomes in acne. J Am Acad Dermatol 49(Suppl 1):S1–S38CrossRefPubMed
22.
23.
24.
Haustein UF, Tegetmeyer L, Ziegler V (1985) Allergic and irritant potential of benzoyl peroxide. Contact Dermat 13(4):252–257CrossRef
25.
Heughebaert C, Shalita A. Comedogenesis (2011) In: Shalita AR, Del Rosso JQ, Webster GF (eds) Acne vulgaris. Informa Healthcare, New York, pp 28–42CrossRef
26.
Hsieh M, Chen C (2011) Delivery of pharmaceutical agents to treat acne vulgaris: current status and perspectives. J Med Biol Eng 32(4):215–224CrossRef
27.
Hui A, Shalita A (2011) Topical retinoids. In: Shalita AR, Del Rosso JQ, Webster GF (eds) Acne vulgaris. Informa Healthcare, London, pp 86–94CrossRef
28.
Jarrousse V, Castex-Rizzi N, Khammari A et al (2007) Modulation of integrins and filaggrin expression by Propionibacterium acnes extracts on keratinocytes. Arch Dermatol Res 299:441–447CrossRefPubMed
29.
Jasson F, Nagy I, Knol AC, Zuliani T, Khammari A, Dréno B (2013) Different strains of Propionibacterium acnes modulate differently the cutaneous innate immunity. Exp Dermatol 22:587–592CrossRefPubMed
30.
Kong HH (2011) Skin microbiome: genomics-based insights into the diversity and role of skin microbes. Trend Mol Med 17:320–328CrossRef
31.
Krishna S, Kim C, Kim J (2011) Innate immunity in the pathogenesis of acne vulgaris. In: Shalita AR, Del Rosso JQ, Webster GF (eds) Acne vulgaris. Informa Healthcare, London, pp 12–27
32.
Kumar B, Pathak R, Mary PB et al (2016) New insights into acne pathogenesis: exploring the role of acne-associated microbial populations. Dermatol Sin 34(2):67–73CrossRef
33.
Kurokawa I, Mayer-da-Silva A, Gollnick H et al (1988) Monoclonal antibody labeling for cytokeratins and filaggrin in the human pilosebaceous unit of normal, seborrhoeic and acne skin. J Invest Dermatol 91:566–571CrossRefPubMed
34.
Marples RR, Downing DT, Kligman AM (1971) Control of free fatty acids in human surface lipids by Corynebacterium acnes. J Invest Dermatol 56:127–131CrossRefPubMed
35.
Mueller NT, Bakacs E, Combellick J, Grigoryan Z, Dominguez-Bello MG (2015) The infant microbiome development: mom matters. Trend Mol Med 21(2):109–17CrossRef
36.
Muszer M, Noszczyńska M, Kasperkiewicz K, Skurnik M (2015) Human microbiome: when a friend becomes an enemy. Arch Immunol Ther Exp (Warsz) 63(4):287–98CrossRef
37.
38.
Nakamura M, Kametani IS, Higaki S, Yamagishi T (2003) Identification of Propionibacterium acnes by polymerase chain reaction for amplification of 16S ribosomal RNA and lipase genes. Anaerobe 9(1):5–10CrossRefPubMed
39.
Ottaviani M, Alestas T, Flori E, Mastrofrancesco A, Zouboulis CC, Picardo M (2006) Peroxidated squalene induces the production of inflammatory mediators in HaCaT keratinocytes: a possible role in acne vulgaris. J Invest Dermatol 126:2430–2437CrossRefPubMed
40.
41.
42.
Pathak R, Kasama N, Kumar R, Gautman HK (2013) Staphylococcus epidermidis in human skin microbiome associated with acne: a cause of disease or defence? Res J Biotech 8(12):78–82
43.
Plewig G, Kligman AM (2000) Sebaceous glands. In: Plewig G, Kligman AM (eds) Acne and rosacea, vol 70, 3rd edn. Springer, BerlinCrossRef
44.
Ritvo E, Del Rosso J, Stillman MA et al (2011) Psychosocial judgments and perceptions of adolescents with acne vulgaris: a blinded, controlled comparison of adult and peer evaluations. Biopsychosoc Med 5:11–26CrossRefPubMedPubMedCentral
45.
Rosenthal M, Goldberg D’Aiello A et al (2011) Skin microbiota: microbial community structure and its potential association with health and disease. Infect Genet Evol 11:839–848CrossRefPubMedPubMedCentral
46.
47.
Smith RN, Braue A, Varigos GA, Mann NJ (2008) The effect of a low glycemic load diet on acne vulgaris and the fatty acid composition of skin surface triglycerides. J Dermatol Sci 50:41–52CrossRefPubMed
48.
49.
Subramanyan K (2004) Role of mild cleansing in management of patient skin. Dermatol Ther 17:26–34CrossRefPubMed
50.
Tagami H (2008) Location-related differences in structure and function of the stratum corneum with special emphasis on facial skin. Int J Cosmet Sci 30:413–434CrossRefPubMed
51.
Tanghetti EA, Popp KF (2009) A current review of topical benzoyl peroxide: new perspectives on formulation and utilization. Dermatol Clin 27:17–24CrossRefPubMed
52.
Tanghetti E, Dhawan S, Green L et al (2010) Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris. J Drugs Dermatol 9(5):549–58PubMed
53.
Thiboutot D, Del Rosso JQ (2013) Acne vulgaris and the epidermal barrier. Is acne vulgaris associated with inherent epidermal abnormalities that cause impairment of barrier functions? Do any topical acne therapies alter the structural and/or functional integrity of the epidermal barrier? J Clin Aesthet Dermatol 6(1):18–24PubMedPubMedCentral
54.
Thiboutot D, Gilliland K, Light J (1999) Androgen metabolism in sebaceous glands from subjects with and without acne. Arch Dermatol 135:1041–1045PubMed
55.
56.
Weber SU, Thiele JJ, Han N et al (2003) Topical tocotrienol supplementation inhibits lipid peroxidation but fails to mitigate increased transepidermal water loss after benzoyl peroxide treatment of human skin. Free Radic Biol Med 34:170–176CrossRefPubMed
57.
Webster GF, Kim J (2008) Immunology of acne. In: Gaspari AA, Tyring SK (eds) Clinical and basic immunodermatology. Springer, London, pp 217–222CrossRef
58.
Wolf JE Jr (2002) Potential anti-inflammatory effects of topical retinoids and retinoid analogues. Adv Ther 19(3):109–118CrossRefPubMed
59.
Yamamoto A, Takenouchi K, Ito M (1995) Impaired water barrier function in acne vulgaris. Arch Dermatol Res 287(2):214–218CrossRefPubMed
60.
Yazici K, Baz K, Yazici A (2004) Disease-specificquality of life is associated with anxiety and depression in patients with acne. J Eur Acad Dermatol Venereol 18:435–439CrossRefPubMed
61.
Zhang YQ, Ren SX, Li HL et al (2003) Genome-based analysis of virulence genes in a non-biofilm-forming Staphylococcus epidermidis strain (ATCC 12228). Mol Microbiol 49:1577–1593CrossRefPubMed
62.
63.
Zouboulis CC, Schagen S, Alestas T (2008) The sebocyte culture: a model to study the pathophysiology of the sebaceous gland in sebostasis, seborrhoea and acne. Arch Dermatol Res 300:397–413CrossRefPubMed
64.
65.
66.
Maguire M, Maguire G (2017) The role of microbiota, and probiotics and prebiotics in skin health. Arch Dermatol Res 309:411–421CrossRefPubMed
67.
Patwardhan SV, Richter C, Vogt A, Blume-Peytavi U, Canfield D, Kottner J (2017) Measuring acne using Coproporphyrin III, Protoporphyrin IX, and lesion-specific inflammation: an exploratory study. Arch Dermatol Res 309:159–167CrossRefPubMedPubMedCentral
68.
Younis S, Blumenberg M, Javed Q (2016) Resistin gene polymorphisms are associated with acne and serum lipid levels, providing a potential nexus between lipid metabolism and inflammation. Arch Dermatol Res 308:229–237CrossRefPubMed
Metadata
Title
Skin barrier and microbiome in acne
Authors
M. A. Rocha
E. Bagatin
Publication date
01-04-2018
Publisher
Springer Berlin Heidelberg
Published in
Archives of Dermatological Research / Issue 3/2018
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-017-1795-3

Other articles of this Issue 3/2018

Archives of Dermatological Research 3/2018 Go to the issue

Original Paper

Evaluating the accuracy of microRNA27b and microRNA137 as biomarkers of activity and potential malignant transformation in oral lichen planus patients

Original Paper

Investigating the roles of regulatory T cells, mast cells and interleukin-9 in the control of skin inflammation by vitamin D

Concise Communication

Skin depigmenting action of silkworm (Bombyx mori L.) droppings in zebrafish

Original Paper

Subcutaneous injection of multipotent mesenchymal stromal cells admixed with melanoma cells in mice favors tumor incidence and growth: a systematic review and meta-analysis

Original Paper

The stem cell factor-stimulated melanogenesis in human melanocytes can be abrogated by interrupting the phosphorylation of MSK1: evidence for involvement of the p38/MSK1/CREB/MITF axis

Concise Communication

BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid